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Abstract 
BACKGROUND: Treating hot flushes in middle-aged women is an important health issue. Recently, Hypericum 
perforatum and vitex agnus-castus were investigated to decrease hot flushes. This study was conducted to 
compare the efficacy of Hypericum perforatum and vitex agnus-castus in hot flushes among menopausal women.  
METHODS: This was a randomized, double-blinded, controlled trial. The Hypericum perforatum group received 330 
µg Hypericum perforatum and second group received vitex agnus-castus in the same tablet forms. Data were 
analyzed using repeated measurement for comparing Greene Climacteric Scale. 
RESULTS: Trend of Greene Climacteric Scale and hot flushness attack were decreased in both groups and it 
presented a decreasing trend within two months; however, no statistically significant difference was observed 
between the two groups. 
CONCLUSION: It seems that Hypericum perforatum and vitex agnus-castus could be similarly effective in 
decreasing hot flushes. These two medicines did not have any special severe side effects. 
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Introduction1 
Treating hot flushes in middle-aged women is an 
important health issue. Now, hormone therapy 
is used as the main method of treating 
menopause symptoms; however, these 
hormones may cause some side effects and 
complications such as temper changes, abnormal 
uterine bleeding, flatulence, breast tenderness, 
nausea, and headaches.1,2 
Recently, a tendency toward alternative and 




complementary herbal treatment methods has 
emerged.3,4 There are also some alternative 
treatment methods that use herbal medicines to 
decrease menopause complications including 
Ginseng, Hypericum perforatum (St John’s wort), 
vitex agnus-castus (chaste tree/berry), black 
cohosh and Dong quai (Angelica sinensis). Among 
these methods, Hypericum perforatum and vitex 
agnus-castus are the most favored.5-7 These two 
herbs contain substances with selective serotonin 
reuptake inhibitors (SSRIs) or serotonin 
norepinephrine reuptake inhibitors (SNRIs). 
SNRIs are used as anti-depression drugs and 





http://cdjournal.muk.ac.ir,    7 October 
Hypericum perforatum and vitex agnus-castus in hot flushes Ghazanfarpour et al. 
 68     Chron Dis J, Vol. 1, No. 2, Autumn 2013 
 
complications as well.8,9 Therefore, Hypericum 
perforatum is used as an anti-depression drug in 
some countries and due to its two products i.e. 
Hypericin and Hyperforin which prevent and 
control mono-amino oxides enzyme, It exerts 
anti-depression effects.10,11 
Vitex agnus-castus which is another herbal 
medicine could decrease hot flushes via its 
dopaminergic effects. Moreover, under-activity of 
dopaminergic system could cause psychological 
dysfunctions and it has been proved that 
dopaminergic effects of Vitex agnus-castus could 
be effective in decreasing emotional symptoms of 
menopause.7 In previous studies, Vitex agnus-
castus has decreased duration, severity and other 
complications of hot flushes.12,13 In the United 
States and Europe, Vitex agnus-castus is used for 
treating premenstrual syndrome and 
hyperprolactinemia.14 Hence, considering 
previous studies, this study was conducted to 
compare the efficacy of Hypericum perforatum 
and vitex agnus-castus in hot flushes among 
menopausal women. 
Materials and Methods 
This was a randomized, double-blinded, 
controlled trial. Protocol for the study was 
approved by the Ethical Review Board and the 
Dean of Faculty, the Deputy of Educational 
Affairs, and the Educational Affairs 
Administration of the University of Shiraz. 
Participants were selected in an outpatient 
academic medical center in Zeinabieh Hospital 
(Shiraz, Iran) from April 2009 to March 2010 by 
convenience sampling method. Sample size 
calculated 26 subjects in each group according 
to the assumption of type 1 error (alpha) 5%, 
power 90% and mean of difference between the 
two groups equal to 10 score [standard 
deviation (SD) ± 11]. In this study, 64 subjects 
were evaluated (Figure 1). 
Informed consent was obtained and all  
the participants were ensured about the 
confidentiality of information during and after 
the study. Inclusive criteria were 1) age 
between 45-65, 2) last menstrual period 1 year 
ago, 3) serum follicle stimulating hormone level 
of more than 40 mIU/ml, and 4) informed 
consent. Exclusive criteria were 1) existing  
use of Hypericum or Vitex Agnus-castus, 2) 
severe diseases (e.g. heart, liver, kidney or 
metabolic diseases ,psychiatric disorders), 3) 
abnormal thyroid-stimulating hormone 4) 
smoking, and 5) using hormones ,vitamins or 
supplements drugs. 
The participants were allocated by simple 
randomization by a nurse. Each patient 
received a package contain one group drug. 
These packages were prepared by the nurse. 
The Hypericum perforatum group received  
160 mg Hypericum perforatum 3tab/day 
(Goldaru Co, Iran) and the second group 
received vitex agnus-castus 3tab/daily in the 
same tablet forms for 8 weeks. 
Outcome of the study was Greene Climacteric 
Scale and its factors15,16 and hot flushness attacks. 
Assessment of Greene Climacteric Scale and hot 
flushness attacks was done by one blinded 
investigator at the baseline, first and second 
months from the interview. Greene Climacteric 
Scale that developed by Green, measures 
psychological, somatic and vasomotor 
symptoms.16 
Data were entered into SPSS for Windows 
(version 11.5, SPSS Inc., Chicago, IL, USA); 
independent t test was also used for comparing 
quantitative variables in the two groups and 
repeated measurement was used for comparing 
the trend of Greene Climacteric Scale and its 
factors during different visits in the two groups 
according to per-protocol analysis.  
Results 
In this study, 76 subjects participated with a 
mean age of 52.9 ± 4.7 years. The mean 
postmenopausal period was 4.2 ± 3.2 years. Body 
mass index (BMI) was 26.7 ± 4.6. The mean 
number of children was 4.3 ± 2 and the mean 
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Figure 1. The profile of the study population in two groups during the study 
 
statistically significant difference between the 
two groups regarding age, menopause age, 
menarche age and number of children. 
The mean number of hot flushes was 3.6 ± 0.8 
times. 62 subjects (81.6%) were married. No 
statistically significant difference was observed 
between the two groups of Hypericum 
perforatum and vitex agnus-castus regarding 
these variables (Table 1). 
The general trend of Greene Climacteric Scale and 
its domains dropped in both groups and it 
presented a decreasing trend within two months; 
however, no statistically significant difference was 
observed between the two groups and the trend of 
reduction in both groups was similar. Both groups 
had a descending trend in hot flushes as well but 
there was no statistically significant difference 
between the two groups (Table 2) (Figure 2) and  
(Figure 3). Moreover, the percentage of successful 
treatment measured by Greene Climacteric Scale 
and its domains did not have any statistically 
significant difference between the two groups and 
at least 38% improvement was observed in each 
group. The maximum percentage of hot flush 
improvement was (58.7% and 55.5%) and the 
lowest percentage was in somatic domain (38.1% 
and 38.2%) (Table 3). 
Some unexpected side effects were observed 
in the study illustrating in table 4. In the first 
month, some complications and side effects were 
observed in four subjects in the Hypericum 
perforatum group and four other subjects in the 
 
Table 1. Comparison of demographic characteristics of the two groups 
Variables Hypericum perforatum Vitex agnus-castus P 
Age 53.2 ± 4.7 52.7 ± 4.8 0.63 
BMI 27.2 ± 4.8 26.2 ± 4.4 0.34 
Age of menarche 13.4 ± 1.6 13.7 ± 1.6 0.39 
Years after menopause (median) 4 (1-12) 3 (1-14) 0.65 
Number of Children (median) 4 (0-8) 4 (1-10) 0.97 
Married 29 (78.4%) 33 (84.6%) 0.48 




(n = 37) 
Vitex agnus-
castus 















(n = 76) 
 
16 were excluded due 
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Table 2. Changes of value of Greene Climacteric Scale and its factors in the two groups during the study 
Factors Time Hypericum perforatum Vitex agnus-castus P 
Total Baseline 29.54 ± 8.5 29.25 ± 8.7 0.88 
Month 1 22.13 ± 6.8 21.12 ± 7.0 0.53 
Month 2 15.86 ± 5.2 15.94 ± 5.6 0.95 
Psychological Baseline 15.08 ± 5.3 14.84 ± 5.9 0.85 
Month 1 11.1 ± 4.1 10.94 ± 4.8 0.87 
Month 2 7.83 ± 4.0 8.17 ± 3.8 0.7 
Somatic Baseline 6.81 ± 3.3 6.82 ± 3.3 0.99 
Month 1 5.27 ± 2.8 4.71 ± 2.5 0.37 
Month 2 4.05 ± 2.1 4.1 ± 2.4 0.92 
Vasomotor Baseline 6.64 ± 1.5 6.64 ± 1.7 0.98 
Month 1 4.86 ± 1.6 4.69 ± 2 0.48 
Month 2 3.56 ± 1.5 3.25 ± 2.2 0.34 
Hot flushness Baseline 3.67 ± 0.74 3.58 ± 0.84 0.64 
Month 1 1.59 ± 1.38 1.58 ± 1.63 0.98 
Month 2 1.4 ± 1.1 1.53 ± 1.71 0.68 
Analysis was done by independent t test and mean ± SD; SD: standard deviation 
 
 
Figure 2. Comparing the frequency of hot flushness trend between the two groups 
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Table 3. Comparing the percentage of improvement in Greene Climacteric Scale and its factors and 
hot flushness between the two groups 
Index Hypericum perforatum Vitex agnus-castus P 
Greene Climacteric Scale 45.5 ± 12.0 44.8 ± 14.5 0.82 
Psychological 48.3 ± 16.9 44.1 ± 16.8 0.28 
Somatic 38.1 ± 23.7 38.2 ± 23.6 0.98 
Vasomotor 45.8 ± 21.0 49.4 ± 34.9 0.58 
Hot flushness 58.7 ± 34.0 55.5 ± 49.9 0.73 
Analysis was done by independent t test and mean ± SD; SD: standard deviation 
 
Table 4. Occurrence of side effects in the two groups during the study 
Side effect 
Side effects leading to withdrawal Side effects not leading to withdrawal 

















Pain over eyes 0 1 0 0 0 0 0 0 
Rashes  1 0 0 0 0 2 0 0 
Nausea 0 1 0 0 3 3 1 0 
Dry month 0 0 0 0 0 0 0 0 
Dizziness 0 0 2 1 2 3 4 1 
Loss of appetite  0 0 0 0 0 0 0 0 
Headache 1 0 1 1 4 3 4 1 
Lethargy 1 0 0 0 0 0 0 0 
Constipation 1 0 1 0 4 0 2 1 
Diarrhea 0 0 0 0 2 1 2 2 
Total 4 2 4 2 15 12 13 5 
 
vitex agnus-castus group and consequently they 
discontinued medicines. Common mild side 
effects were headache and constipation in the 
Hypericum perforatum group and headache 
and dizziness in the vitex agnus-castus group. 
Discussion 
Our results showed that Hypericum perforatum 
and vitex agnus-castus could reduce Greene 
Climacteric Scale in menopausal women. This 
improvement was observed in all items of 
Greens questionnaire but there was no 
statistically significant difference between the 
two groups. Previous studies have supported 
that Hypericum perforatum is useful in relieving 
the symptoms of menopausal syndrome.7,9 
In our study, the percentage of improvement 
in Greene Climacteric Scale was 45.5% and 
44.8% in Hypericum perforatum and vitex 
agnus-castus groups, respectively. There was no 
statistically significant difference between the 
two herbal drugs. The reasons for using vitex 
agnus-castus in our study were the efficiency, 
safety, and inexpensiveness of this combination 
since Hypericum perforatum is extensively 
found in the mountains of Iran. Furthermore, 
previous studies suggested further investigation 
about these herbal drugs.7 
Previous studies compared Hypericum 
perforatum and placebo7,9 but there are few 
studies comparing Hypericum perforatum and 
vitex agnus-castus.7 Abdali et al.9 showed that 
Hypericum perforatum was an effective 
treatment for vasomotor symptoms and hot 
flushes in premenopausal or postmenopausal 
women; this result was similar to our study 
results. In Abdali et al.9 women who had used 
Hypericum perforatum showed more 
improvement in their frequency of hot flushes 
than the placebo-receiving group. 
Al-Akoum et al.10 indicated that Hypericum 
perforatum ethanolic extract can improve 30% of 
hot flushes. In addition, they found 
improvements in quality of life and its domains 
(vasomotor, physical, and psychosocial aspects) 
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(MENQOL) questionnaire. However, they 
suggested that further studies with larger 
clinical trials are needed. 
Besides, our findings are in accordance with 
Grube et al.17 They reported improvement in 
psychological and psychosomatic symptoms in 
menopausal women. Van Die et al.7 measured 
Hypericum perforatum with vitex agnus-castus 
within menopausal symptoms. They showed 
that Hypericum perforatum and vitex agnus-
castus were not superior to placebo in 
alleviating menopausal symptoms. 
In a study18 concerning the effects of vitex 
agnus-castus on hot flushes and nightly sweating 
among 50 pre and postmenopausal women, it was 
found that vitex agnus-castus was more efficient 
than the placebo. In Chopin 19, 33% showed major 
improvements and 36% mild to moderate 
improvements in symptoms. The most important 
improvement after hot flushes was regarding 
emotional symptoms. In our study, the most 
significant improvement was observed in hot 
flushes and then in psychological symptoms.  
Based on the results of our study and other 
studies, it seems that Hypericum perforatum and 
vitex agnus-castus could be similarly effective in 
decreasing hot flushes. Therefore, taking these 
two substances could be helpful. These two 
medicines do not have any special severe side 
effects and their observed complications such as 
headache might be removed by simple medicinal 
treatments. Similar side effects have been 
observed in other studies as well.10 
Conclusion 
It seems that Hypericum perforatum and vitex 
agnus-castus could be similarly effective in 
decreasing hot flushes. These two medicines do 
not have any special severe side effects. 
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